The S&P’s Most Dramatic Performances of 2013 (And What They Taught Us)

We look at 2013's best and worst performers in the S&P 500, as well as what that might say about returns in 2014. More 

GILD: Get on While Biotech Remains Hot

The bulls seemingly are unwilling to cast off biotech. And among the sector's biggest stocks, Gilead Sciences (GILD) has the most appealing setup. More 

Trade of the Day: Gilead Sciences (GILD)

Use the low-volume atmosphere around the New Year’s holiday to establish positions at a discount. More 

Trade of the Day: Gilead Sciences (GILD)

This market is bullish, with a capital B, and call options are the way to trade it. More 

Rumor Could Give Traders Another Shot at a Top Biotech

Gilead Sciences' (GILD) sell-off on an unconfirmed report may provide a good entry point. More 

Must-Own Biotech Just Issued a New Buy Signal

Gilead Sciences is in a powerful bull channel with accumulation building. Get the target for GILD. More 

5 Best Closed End Funds to Buy

Check out these five great closed end funds that offer investors upside in today’s low-interest-rate environment: More